GlassScriptPhysician profile
Kara J Johnson
NPI 1578708228
$4,305.55
in general payments reported to CMS, 2019-2025
13 companies · $3,620 in 2025
The $3,620 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2021: $76.53 · 2022: $105 · 2023: $132 · 2024: $191 · 2025: $3,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,557 · Travel and Lodging: $1,013 · Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,557.48 |
| Travel and Lodging | $1,012.76 |
| Food and Beverage | $372.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,725.94 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $152.92 | 2019-2022 | |
| Insmed, INC. | $97.44 | 2021-2022 | |
| United Therapeutics Corporation | $73.72 | 2025 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $36.22 | 2019-2025 | Dupixent |
| Amgen INC. | $27.92 | 2022 | |
| Ethicon INC. | $27.81 | 2021 | |
| Baxter Healthcare | $25.94 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Csl Behring | $25.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.86 | 2023 | Ofev |
| Genzyme Corporation | $19.43 | 2023 | |
| Veran Medical Technologies, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.